At least 10 House law­mak­ers are back­ing a US trade pan­el’s probe of Chi­na’s biotech sec­tor and re­lat­ed pric­ing prac­tices, en­cour­ag­ing fu­ture ex­ec­u­tive ac­tion.

In...

Sam­sung Bi­o­log­ics is set to branch in­to pep­tide in­gre­di­ent man­u­fac­tur­ing with plans to buy Swiss CD­MO PolyPep­tide for $1.8 bil­lion in cash.

The pur­chase, an­nounced...

A year ago, An­throp­ic’s life sci­ences plans were ba­si­cal­ly just a blog post by its CEO.

In late 2024, Dario Amod­ei wrote a 13,000-word memo...

John­son & John­son and Ab­b­Vie, the two phar­ma gi­ants al­ready in the psy­che­del­ic space, al­so eyed AtaiBeck­ley, ac­cord­ing to a source fa­mil­iar with the sit­u­a­tion, but...

Bris­tol My­ers Squibb said Mon­day it will build "the most ad­vanced and en­er­gy-ef­fi­cient AI" su­per­com­put­er sys­tem in the bio­phar­ma in­dus­try, deep­en­ing its re­la­tion­ship with Nvidia...